In response to Alqahtani et al. (2015 Jul; 24(7):709-15): suggesting an international regulatory harmonization for priority review drugs need further investigations
- PMID: 27245859
- DOI: 10.1002/pds.3973
In response to Alqahtani et al. (2015 Jul; 24(7):709-15): suggesting an international regulatory harmonization for priority review drugs need further investigations
Comment in
-
Response to letter to the editor regarding Alqahtani et al. Article on priority review drugs approved by the FDA and the EMA: time for international regulatory harmonization of pharmaceuticals?Pharmacoepidemiol Drug Saf. 2016 Jun;25(6):745-6. doi: 10.1002/pds.4010. Pharmacoepidemiol Drug Saf. 2016. PMID: 27245860 No abstract available.
Comment on
-
Priority review drugs approved by the FDA and the EMA: time for international regulatory harmonization of pharmaceuticals?Pharmacoepidemiol Drug Saf. 2015 Jul;24(7):709-15. doi: 10.1002/pds.3793. Epub 2015 May 27. Pharmacoepidemiol Drug Saf. 2015. PMID: 26013294
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
